PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.415
-0.025 (-1.74%)
Sep 5, 2025, 12:04 PM - Market open
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $74.98 million as of September 5, 2025. Its market cap has decreased by -9.60% in one year.
Market Cap
74.98M
Enterprise Value
-70.98M
1-Year Change
-9.60%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $74.98M, a decrease of -95.35%. That is a compound annual growth rate of -46.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 82.14M | 5.12% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
| Sep 25, 2020 | 1.61B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.38B |
| Johnson & Johnson | 428.68B |
| AbbVie | 374.26B |
| UnitedHealth Group | 278.84B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 253.55B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 230.05B |